Latest filing published 06 Jul 2026 for Integra Lifesciences Holdings CORP, €15k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jeffrey Mosebrook discloses dealings in Integra Lifesciences Holdings Corp to SEC (Form 4). In total, 20 filings cover trades dated from 10 November 2021 to 1 July 2026.
Sales make up the whole of the open-market record (5 sales, €153k). Other entries cover 15 share grants.
Most recently, on 6 July 2026, the filings show a share grant worth €15k in Integra Lifesciences Holdings Corp. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations